CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹1,081 Cr | ₹951 Cr | ₹754 Cr | ₹536 Cr | ₹288 Cr |
What is the latest Net Current Assets ratio of CONCORD BIOTECH ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹1,081 Cr |
| Mar2025 | ₹951 Cr |
| Mar2024 | ₹754 Cr |
| Mar2023 | ₹536 Cr |
| Mar2022 | ₹288 Cr |
How is Net Current Assets of CONCORD BIOTECH Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,081 Cr | 13.65 | |
| Mar2025 | ₹951 Cr | 26.14 | |
| Mar2024 | ₹754 Cr | 40.72 | |
| Mar2023 | ₹536 Cr | 85.79 | |
| Mar2022 | ₹288 Cr | - | |
Compare Net Current Assets of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹14,169.6 Cr | -5.4% | -7.3% | -13.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,562.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,572.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,871.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹107,770.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,829.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | -5.4% |
-7.3% |
-13.7% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses